A Post-Marketing Surveillance Study on NesinaAct® Tablet Use Among Type 2 Diabetes Mellitus Participants in Korea

NCT04980014 · clinicaltrials.gov ↗

COMPLETED

Status

730

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: NesinaAct® Tablet

Sponsor

Takeda